These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 18425892)

  • 21. Transdermal nicotine for induction of remission in ulcerative colitis.
    McGrath J; McDonald JW; Macdonald JK
    Cochrane Database Syst Rev; 2004 Oct; (4):CD004722. PubMed ID: 15495126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclosporine for induction of remission in Crohn's disease.
    McDonald JW; Feagan BG; Jewell D; Brynskov J; Stange EF; Macdonald JK
    Cochrane Database Syst Rev; 2005 Apr; (2):CD000297. PubMed ID: 15846602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aminosalicylates for induction of remission or response in Crohn's disease.
    Lim WC; Hanauer S
    Cochrane Database Syst Rev; 2010 Dec; (12):CD008870. PubMed ID: 21154400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rectal 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
    Marshall JK; Thabane M; Steinhart AH; Newman JR; Anand A; Irvine EJ
    Cochrane Database Syst Rev; 2012 Nov; 11():CD004118. PubMed ID: 23152224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methotrexate for induction of remission in ulcerative colitis.
    Chande N; MacDonald JK; McDonald JW
    Cochrane Database Syst Rev; 2007 Oct; (4):CD006618. PubMed ID: 17943916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis.
    Chande N; McDonald JW; Macdonald JK; Wang JJ
    Cochrane Database Syst Rev; 2010 Oct; (10):CD006774. PubMed ID: 20927749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic review: microscopic colitis.
    Nyhlin N; Bohr J; Eriksson S; Tysk C
    Aliment Pharmacol Ther; 2006 Jun; 23(11):1525-34. PubMed ID: 16696800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral budesonide for induction of remission in ulcerative colitis.
    Sherlock ME; Seow CH; Steinhart AH; Griffiths AM
    Cochrane Database Syst Rev; 2010 Oct; (10):CD007698. PubMed ID: 20927762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacotherapy for inducing and maintaining remission in pouchitis.
    Sandborn W; McLeod R; Jewell D
    Cochrane Database Syst Rev; 2000; (2):CD001176. PubMed ID: 10796613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis.
    Timmer A; McDonald JW; Tsoulis DJ; Macdonald JK
    Cochrane Database Syst Rev; 2012 Sep; (9):CD000478. PubMed ID: 22972046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of budesonide in collagenous colitis Evaluation of: Miehlke S, Madisch A, Kupcinskas L, et al. Budesonide is more effective than mesalamine or placebo in short-term treatment of collagenous colitis. Gastroenterology 2014;146(5):1222-1230 e1222.
    Drug VL; Antoniu SA
    Expert Opin Pharmacother; 2014 Oct; 15(15):2277-9. PubMed ID: 25164577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Budesonide for maintenance of remission in Crohn's disease.
    Benchimol EI; Seow CH; Otley AR; Steinhart AH
    Cochrane Database Syst Rev; 2009 Jan; (1):CD002913. PubMed ID: 19160212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis.
    Singh S; Stroud AM; Holubar SD; Sandborn WJ; Pardi DS
    Cochrane Database Syst Rev; 2015 Nov; (11):CD001176. PubMed ID: 26593456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral budesonide for maintenance treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial.
    Miehlke S; Madisch A; Bethke B; Morgner A; Kuhlisch E; Henker C; Vogel G; Andersen M; Meier E; Baretton G; Stolte M
    Gastroenterology; 2008 Nov; 135(5):1510-6. PubMed ID: 18926826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Budesonide Versus Mesalamine in Microscopic Colitis: A Comparative Meta-analysis of Randomized Controlled Trials.
    Malik A; Goyal H; Adler DG; Javaid S; Malik MI; Singh S; Nadir A; Abegunde AT
    J Clin Gastroenterol; 2024 Jul; ():. PubMed ID: 39042479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meta-analysis: budesonide treatment for collagenous colitis.
    Feyen B; Wall GC; Finnerty EP; DeWitt JE; Reyes RS
    Aliment Pharmacol Ther; 2004 Oct; 20(7):745-9. PubMed ID: 15379834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical characteristics and patterns and predictors of response to therapy in collagenous and lymphocytic colitis.
    Colussi D; Salari B; Stewart KO; Lauwers GY; Richter JR; Chan AT; Ricciardiello L; Khalili H
    Scand J Gastroenterol; 2015; 50(11):1382-8. PubMed ID: 25997458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natalizumab for induction of remission in Crohn's disease.
    Macdonald JK; McDonald JW
    Cochrane Database Syst Rev; 2006 Jul; (3):CD006097. PubMed ID: 16856112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term budesonide treatment of collagenous colitis: a randomised, double-blind, placebo-controlled trial.
    Bonderup OK; Hansen JB; Teglbjaerg PS; Christensen LA; Fallingborg JF
    Gut; 2009 Jan; 58(1):68-72. PubMed ID: 18669576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natalizumab for induction of remission in Crohn's disease.
    MacDonald JK; McDonald JW
    Cochrane Database Syst Rev; 2007 Jan; (1):CD006097. PubMed ID: 17253580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.